{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:46:07Z","timestamp":1789749967661,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.11.061","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T06:49:40Z","timestamp":1450421380000},"page":"1115-1125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy"],"prefix":"10.1016","volume":"34","author":[{"given":"Anuj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranajoy","family":"Mullick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjitha","family":"Tatineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5878-0482","authenticated-orcid":false,"given":"Debashree","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Torresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric James","family":"Gowans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali Anoop","family":"Karande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumitra","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.11.061_bib0195","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.addr.2007.04.014","article-title":"Hepatitis C viral life cycle","volume":"59","author":"Suzuki","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0200","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/gut.2003.037788","article-title":"Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance","volume":"53","author":"Spada","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0205","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature04081","article-title":"Prospects for a vaccine against the hepatitis C virus","volume":"436","author":"Houghton","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00535-007-2030-3","article-title":"Molecular biology of hepatitis C virus","volume":"42","author":"Suzuki","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0215","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2012.10.019","article-title":"Perspectives and challenges of interferon-free therapy for chronic hepatitis C","volume":"58","author":"Lange","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1586\/egh.12.72","article-title":"Hepatitis C virus vaccines in the era of new direct acting antivirals","volume":"7","author":"Shi","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0225","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3390\/v3112127","article-title":"Neutralizing antibody response to hepatitis C virus","volume":"3","author":"Wang","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0235","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.20934","article-title":"Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee","volume":"42","author":"Youn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0240","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Rold\u00e3o","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1053\/jhep.2001.26523","article-title":"Hepatitis C virus-like particles induce virus-specific humoral and cellular immune response in mice","volume":"34","author":"Lechmann","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0250","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1128\/JVI.78.13.6995-7003.2004","article-title":"Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in non-human primates","volume":"78","author":"Jeong","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0255","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.0702162104","article-title":"Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees","volume":"104","author":"Elmowalid","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0260","doi-asserted-by":"crossref","first-page":"94ra71","DOI":"10.1126\/scitranslmed.3002330","article-title":"A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques","volume":"3","author":"Garrone","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0265","doi-asserted-by":"crossref","first-page":"e53619","DOI":"10.1371\/journal.pone.0053619","article-title":"Monoclonal antibodies against Hepatitis C virus genotype 3a like particle inhibit virus entry in cell culture system","volume":"8","author":"Das","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0270","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jmv.20561","article-title":"Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease","volume":"78","author":"Hissar","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0275","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the AdEasy system","volume":"2","author":"Luo","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0280","doi-asserted-by":"crossref","first-page":"e47492","DOI":"10.1371\/journal.pone.0047492","article-title":"Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses","volume":"7","author":"Chua","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0285","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1128\/JVI.72.5.3827-3836.1998","article-title":"Hepatitis C virus structural proteins assemble into virus like particles in insect cells","volume":"72","author":"Baumert","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0290","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1038\/nprot.2006.395","article-title":"Cell culture and infection system for hepatitis C virus","volume":"1","author":"Kato","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0295","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-422X-9-11","article-title":"Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell","volume":"9","author":"Asad","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0305","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.3183","article-title":"Current progress in development of hepatitis C virus vaccines","volume":"19","author":"Liang","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0310","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T-cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0315","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.03574-13","article-title":"Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses","volume":"88","author":"Chmielewska","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0320","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis c virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0325","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0330","doi-asserted-by":"crossref","first-page":"e1002895","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0335","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0340","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2010.06.084","article-title":"Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults","volume":"28","author":"Frey","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.11.061_bib0345","doi-asserted-by":"crossref","first-page":"e59776","DOI":"10.1371\/journal.pone.0059776","article-title":"A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1\/gpE2 derived from a single isolate elicits broad cross-genotypic neutralizing antibodies in humans","volume":"8","author":"Law","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0350","doi-asserted-by":"crossref","first-page":"14278","DOI":"10.1128\/JVI.01911-14","article-title":"A recombinant HCV envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization","volume":"88","author":"Wong","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0355","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/hep.24171","article-title":"In vivo evaluation of the cross-genotype neutralizing ability of polyclonal antibodies against hepatitis C virus","volume":"53","author":"Meuleman","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0360","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2013.05.007","article-title":"Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice","volume":"145","author":"Akazawa","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.035956-0","article-title":"The role of neutralizing antibodies in hepatitis C virus infection","volume":"93","author":"Edwards","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0370","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0375","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2014.07.005","article-title":"Signatures of protective memory immune responses during hepatitis C virus reinfection","volume":"147","author":"Abdel-Hakeem","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2015.11.061_bib0380","doi-asserted-by":"crossref","first-page":"e95103","DOI":"10.1371\/journal.pone.0095103","article-title":"Strong vaccine-induced CD8 T-cell responses have cytolytic function in a chimpanzee clearing HCV infection","volume":"9","author":"Verstrepen","year":"2014","journal-title":"PLOS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15017272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15017272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T22:54:17Z","timestamp":1599951257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15017272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X15017272"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}